Abstract
Methods for risk-stratifying prostate cancer should be improved. This review-article includes 15 articles assessing the value of MRI in an active surveillance (AS) setting. In patients with low risk disease, the MRI generally is non-suspicious, which may be used within AS selection and follow-up. Higher risk disease is however not always detected with MRI. The place of MRI within prostate cancer diagnostics and treatment should still be determined.
MRI and active surveillance for low risk prostate cancer.
Translated title of the contribution | MRI and active surveillance for low risk prostate cancer |
---|---|
Original language | Dutch |
Pages (from-to) | 185-191 |
Number of pages | 7 |
Journal | Tijdschrift voor Urologie |
Volume | 4 |
Issue number | 8 |
DOIs | |
Publication status | Published - 1 Jan 2014 |